Powered by

-Helius Medical Technologies Inc. Submits Request for FDA Clearance for PoNS Device

Aug 07, 2020 - ENP Newswire
Financial Results

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX: HSM) ('Helius' or the 'Company'), a neurotech company focused on neurological wellness, today announced that it has submitted a request to the U.S. Food and Drug Administration ('FDA') for de novo classification and clearance of the Portable Neuromodulation Stimulator (PoNSTM) device and reported preliminary financial results for the second quarter and six months ended June 30, 2020.

The PoNS device was granted Breakthrough Desig...